AngioDynamics, Inc.
AngioDynamics, Inc.（ANGO）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ANGO · 截至 2026年6月9日
活动摘要
买入笔数
7
P-Purchase only
卖出笔数
1
近12个月
买卖比
7.00
Buy/Sell (by trades)
整体情绪
AngioDynamics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ANGO 季度内部人买卖趋势
ANGO 内幕交易卖出 · ANGO 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · ANGO CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ANGO 高管卖出股份 · ANGO 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Oct 21, 2025 | Weiss Lawrence T SVP, Chief Legal Officer | Purchase | 10,000 | $118K | Form 4 |
| Oct 13, 2025 | Trowbridge Stephen A EVP and CFO | Purchase | 890 | $10K | Form 4 |
| Oct 9, 2025 | Clemmer James C President and CEO · Director | Purchase | 10,000 | $112K | Form 4 |
| Jul 19, 2025 | Trowbridge Stephen A EVP and CFO | Other | 2,585 | $22K | Form 4 |
| Jul 20, 2025 | Trowbridge Stephen A EVP and CFO | Other | 717 | $6K | Form 4 |
| Jul 21, 2025 | Trowbridge Stephen A EVP and CFO | Other | 667 | $6K | Form 4 |
| Jul 19, 2025 | Piccinini Laura SVP International | Other | 1,983 | $17K | Form 4 |
| Jul 20, 2025 | Piccinini Laura SVP International | Other | 616 | $5K | Form 4 |
| Jul 19, 2025 | Nighan Warren JR SVP Quality and Regulatory | Other | 735 | $6K | Form 4 |
| Jul 20, 2025 | Nighan Warren JR SVP Quality and Regulatory | Other | 251 | $2K | Form 4 |
| Jul 21, 2025 | Nighan Warren JR SVP Quality and Regulatory | Other | 277 | $2K | Form 4 |
| Jul 19, 2025 | Clemmer James C President and CEO · Director | Other | 344 | $3K | Form 4 |
| Jul 19, 2025 | Clemmer James C President and CEO · Director | Other | 8,307 | $72K | Form 4 |
| Jul 20, 2025 | Clemmer James C President and CEO · Director | Other | 2,982 | $26K | Form 4 |
| Jul 20, 2025 | Clemmer James C President and CEO · Director | Other | 3,673 | $33K | Form 4 |
| Jul 19, 2025 | Campbell Chad Thomas SVP/GM, Vascular Access | Other | 1,025 | $9K | Form 4 |
| Jul 20, 2025 | Campbell Chad Thomas SVP/GM, Vascular Access | Other | 359 | $3K | Form 4 |
| Jul 21, 2025 | Campbell Chad Thomas SVP/GM, Vascular Access | Other | 395 | $4K | Form 4 |
| Jul 17, 2025 | Piccinini Laura SVP International | Other | 3,074 | $27K | Form 4 |
| Jul 16, 2025 | Nighan Warren JR SVP Quality and Regulatory | Award | 29,349 | — | Form 4 |
| Jul 16, 2025 | Clemmer James C President and CEO · Director | Award | 206,253 | — | Form 4 |
| Jul 16, 2025 | Weiss Lawrence T SVP, Chief Legal Officer | Award | 30,900 | — | Form 4 |
| Jul 16, 2025 | Trowbridge Stephen A EVP and CFO | Award | 86,997 | — | Form 4 |
| Jul 16, 2025 | Campbell Chad Thomas SVP/GM, Vascular Access | Award | 26,268 | — | Form 4 |
| Jul 16, 2025 | DONNELLY HOWARD W Director | Award | 17,675 | — | Form 4 |
Weiss Lawrence T
SVP, Chief Legal Officer
日期
Oct 21
股数
10,000
均价
$11.81
总金额
$118K
Clemmer James C
President and CEO · Director
日期
Oct 9
股数
10,000
均价
$11.15
总金额
$112K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ANGO 内幕交易
ANGO 内幕交易
AngioDynamics, Inc.（ANGO）内幕交易数据来源于公司内部人（包括Clemmer James C (President and CEO · Director), Trowbridge Stephen A (EVP and CFO), Piccinini Laura (SVP International)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ANGO内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看AngioDynamics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ANGO 内幕交易 · 5个问题AngioDynamics, Inc.（ANGO）的内部人包括高管和董事，如Clemmer James C (President and CEO · Director), Trowbridge Stephen A (EVP and CFO), Piccinini Laura (SVP International)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026